| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| ICICI Pru Healthcare ETF |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.15 |
| Equity |
99.85 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
49.50% |
| Top 10 Holdings |
77.62% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
79.82 |
| Healthcare |
20.03 |
| Cash |
0.15 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.52 |
| PE Ratio |
43.75 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Ltd. |
18.30 |
| Divis Laboratories Ltd. |
8.89 |
| Apollo Hospitals Enterprises Ltd. |
8.01 |
| Cipla Ltd. |
7.20 |
| Max Healthcare Institute Limited |
7.10 |
| Torrent Pharmaceuticals Ltd. |
6.53 |
| Laurus Labs Limited |
6.14 |
| Dr. Reddys Laboratories Ltd. |
6.08 |
| Lupin Ltd |
5.09 |
| Fortis Healthcare Ltd |
4.28 |
| Aurobindo Pharma Ltd. |
3.80 |
| Glenmark Pharmaceuticals ltd |
2.92 |
| Alkem Laboratories Limited |
2.92 |
| Biocon Ltd. |
2.64 |
| Zydus Lifesciences Limited |
2.45 |
| Mankind Pharma Limited |
2.43 |
| Ipca Laboratories Ltd. |
2.11 |
| Abbott India Ltd. |
1.26 |
| PIRAMAL PHARMA LIMITED |
1.06 |
| Syngene International Limited |
0.64 |
| Net Current Assets |
0.15 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|